Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA

Articles by Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA

Cecilia BrownVideo Insights | June 8, 2023
Dr. Dickinson discusses major updates to be presented during the 2023 European Hematology Association Congress.
View More
Cecilia BrownMeeting News | June 8, 2023
Dr. Dickinson and colleagues presented the research at the 2023 American Society of Clinical Oncology Annual Meeting.
Cecilia BrownMeeting News | September 5, 2023
Dr. Dickinson discusses what he sees as the key highlights in lymphoma research during the summer 2023 conference season.
Michael Dickinson, MBBS, DMedSc, FRACP, FRACPAVideo Insights | January 20, 2023
Michael Dickinson, MBBS, DMedSc, discusses trials in progress that are evaluating glofitamab with other agents for DLBCL.
Michael Dickinson, MBBS, DMedSc, FRACP, FRACPAVideo Insights | January 18, 2023
Michael Dickinson, MBBS, DMedSc, discusses a phase II trial of glofitamab, a bispecific antibody, in patients with DLBCL.
Michael Dickinson, MBBS, DMedSc, FRACP, FRACPAVideo Insights | February 3, 2023
Michael Dickinson, MBBS, DMedSc, discusses updates on glofitamab that were presented during the 2022 ASH meeting.